BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 100 filers reported holding BIOSCRIP INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $6,000 | -95.6% | 2,272 | -96.7% | 0.00% | -100.0% |
| Q1 2019 | $137,000 | +878.6% | 68,735 | +1660.6% | 0.01% | +700.0% |
| Q4 2018 | $14,000 | +55.6% | 3,904 | +36.8% | 0.00% | 0.0% |
| Q3 2018 | $9,000 | -18.2% | 2,854 | -54.8% | 0.00% | 0.0% |
| Q1 2017 | $11,000 | -84.7% | 6,318 | -39.2% | 0.00% | -90.0% |
| Q3 2014 | $72,000 | +1700.0% | 10,400 | +1980.0% | 0.01% | +900.0% |
| Q3 2013 | $4,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coliseum Capital Management, LLC | 5,622,410 | $5,847,000 | 2.64% |
| NORTH TIDE CAPITAL, LLC | 8,500,000 | $8,840,000 | 1.51% |
| WYNNEFIELD CAPITAL INC | 3,700,000 | $3,848,000 | 1.39% |
| Alta Fundamental Advisers LLC | 2,330,774 | $2,424,000 | 1.20% |
| ARDSLEY ADVISORY PARTNERS LP | 6,350,000 | $6,604,000 | 1.09% |
| Camber Capital Management LP | 10,180,000 | $10,587,000 | 0.55% |
| PERKINS CAPITAL MANAGEMENT INC | 298,000 | $310,000 | 0.34% |
| Hawk Ridge Capital Management | 340,429 | $354,000 | 0.18% |
| Eidelman Virant Capital | 220,000 | $228,000 | 0.13% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 227,280 | $236,000 | 0.11% |